601
Participants
Start Date
May 3, 2018
Primary Completion Date
April 5, 2022
Study Completion Date
April 5, 2022
Letermovir
LET 480mg (or 240 mg when administered concomitantly with cyclosporin A) once daily for 28 weeks
Valganciclovir
900 mg VGCV tablet orally, once daily for 28 weeks
Acyclovir (ACV)
400 mg over-encapsulated ACV tablet orally, every 12 hours for 28 weeks
Placebo to ACV
Over-encapsulated placebo tablet orally, every 12 hours for 28 weeks
Placebo to LET
Placebo to LET tablet orally, once daily for 28 weeks
Placebo to VGCV
Placebo to VGCV tablet orally, once daily for 28 weeks
Cliniques Universitaires de Bruxelles - CUB - Hopital Erasme ( Site 0042), Brussels
Semmelweis Egyetem ( Site 0281), Budapest
Allgemeines Krankenhaus Universitaetskliniken Wien ( Site 0032), Vienna
Auckland City Hospital ( Site 0002), Auckland
Royal Prince Alfred Hospital ( Site 0005), Camperdown
Westmead Hospital ( Site 0006), Westmead
Universitair Ziekenhuis Antwerpen ( Site 0041), Edegem
UZ Leuven - Campus Gasthuisberg ( Site 0044), Leuven
Royal Melbourne Hospital ( Site 0007), Parkville
Monash Health-Monash Medical Centre ( Site 0008), Clayton
Debreceni Egyetem. ( Site 0283), Debrecen
Princess Alexandra Hospital ( Site 0004), Woolloongabba
Royal Adelaide Hospital ( Site 0003), Adelaide
Medizinische Universitat Innsbruck ( Site 0033), Innsbruck
Szegedi Tudomanyegyetem ( Site 0284), Szeged
Pecsi Tudomanyegyetem AOK ( Site 0282), Pécs
Icahn School of Medicine at Mount Sinai ( Site 0256), New York
Columbia University Medical Center ( Site 0255), New York
New York Presbyterian Hospital - Weill Cornell Medical Center ( Site 0276), New York
Charite Universitaetsmedizin Berlin ( Site 0071), Berlin
A.O.U. Citta della Salute e della Scienza di Torino ( Site 0096), Turin
Instituto Nacional de Cardiologia Ignacio Chavez ( Site 0213), Mexico City
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( Site 0214), Mexico City
University of Pittsburgh ( Site 0252), Pittsburgh
University of Pennsylvania ( Site 0270), Philadelphia
IRCCS Ospedale San Raffaele di Milano ( Site 0098), Milan
Centenario Hospital Miguel Hidalgo ( Site 0215), Aguascalientes
University of Maryland Medical Center ( Site 0234), Baltimore
Johns Hopkins Hospital ( Site 0232), Baltimore
Virginia Commonwealth University ( Site 0245), Richmond
Wake Forest University Baptist Medical Center ( Site 0260), Winston-Salem
Duke University Medical Center ( Site 0243), Durham
Hospital Doce de Octubre ( Site 0116), Madrid
Medical University of South Carolina ( Site 0257), Charleston
The Emory Clinic ( Site 0247), Atlanta
Medizinische Hochschule Hannover ( Site 0073), Hanover
CHU Rangueil ( Site 0054), Toulouse
CHU de Bordeaux. Hopital Pellegrin ( Site 0055), Bordeaux
Azienda Ospedaliera di Padova U.O.C. Trapianti Rene e Pancreas ( Site 0091), Padua
UAB ( Site 0269), Birmingham
Vanderbilt University Medical Center ( Site 0275), Nashville
The Ohio State University Wexner Medical Center ( Site 0264), Columbus
C.H.R.U Bretonneau ( Site 0051), Tours
Universitaetsklinikum Essen ( Site 0074), Essen
Indiana University ( Site 0261), Indianapolis
Henry Ford Hospital ( Site 0242), Detroit
Hospital Universitario Miguel Servet ( Site 0118), Zaragoza
Hopital Pasteur ( Site 0053), Nice
University of Chicago ( Site 0251), Chicago
Instituto Mexicano de Trasplantes S C ( Site 0212), Cuernavaca
University of Nebraska Medical Center ( Site 0272), Omaha
Ochsner Clinic Foundation ( Site 0238), New Orleans
Hopital Tenon ( Site 0061), Paris
UCLA Medical Center ( Site 0266), Los Angeles
Faicic S de RL de CV ( Site 0211), Veracruz
Hopital Henri Mondor du Creteil ( Site 0063), Créteil
University of California-San Francisco ( Site 0236), San Francisco
CHU - Hopital de Bicetre ( Site 0060), Le Kremlin-Bicêtre
Stanford Health Care ( Site 0235), Stanford
UC Davis Medical Center ( Site 0271), Sacramento
University of Washington Medical Center ( Site 0246), Seattle
Clinica del Country ( Site 0208), Bogotá
Clinica Colsanitas S.A. Sede Clinica Universitaria Colombia ( Site 0209), Bogotá
Hospital Universitario Mayor Mederi CIMED ( Site 0206), Bogotá
Sociedad de Cirugia de Bogota Hospital de San Jose ( Site 0203), Bogotá
Fundacion Cardiovascular de Colombia ( Site 0210), Bucaramanca
Fundacion Valle del Lili ( Site 0285), Santiago de Cali
Centro Medico Imbanaco de Cali S.A ( Site 0201), Santiago de Cali
Brigham & Women's Hospital ( Site 0244), Boston
Saint Barnabas Medical Center ( Site 0250), Livingston
Hospital El Cruce Nestor Carlos Kirchner ( Site 0351), San Juan Bautista
CEMIC ( Site 0352), Buenos Aires
Instituto de Nefrologia Nephrology S.A. ( Site 0182), Buenos Aires
Hospital Italiano de Buenos Aires ( Site 0188), CABA
Instituto de Cardiología de Corrientes Juana F. Cabral ( Site 0181), Corrientes
Clinica de nefrologia urologia y enfermedades cardiovasculares ( Site 0354), Santa Fe
University of Alberta Hospital ( Site 0221), Edmonton
Vancouver General Hospital ( Site 0224), Vancouver
St. Paul's Hospital ( Site 0225), Vancouver
Toronto General Hospital ( Site 0222), Toronto
Hopital Maisonneuve-Rosemont CIUSSS de l Est de L Ile de Montreal ( Site 0226), Montreal
Hospital San Vicente Fundación - Rionegro ( Site 0205), Rionegro
Policlinico Gemelli Instituto di Clinica Chirurgica ( Site 0093), Roma
Szpital Wojewodzki w Poznaniu ( Site 0168), Poznan
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego ( Site 0162), Wroclaw
Szpital Kliniczny Dzieciatka Jezus ( Site 0165), Warsaw
Uniwersyteckie Centrum Kliniczne ( Site 0170), Gdansk
Pomorski Uniwersytet Medyczny ( Site 0167), Szczecin
Hospital del Mar ( Site 0121), Barcelona
Hospital Universitari de Bellvitge IDIBELL ( Site 0114), L'Hospitalet de Llobregat
Hospital Universitari Vall de Hebron ( Site 0112), Barcelona
Hospital Clinic i Provincial de Barcelona ( Site 0113), Barcelona
St Georges University Hospitals NHS Foundation Trust. ( Site 0136), London
Queen Elizabeth Hospital ( Site 0356), Birmingham
Merck Sharp & Dohme LLC
INDUSTRY